“…Surgical resection is the basis of treatment of GISTs and treatment with Imatinib, a tyrosine kinase inhibitor, is beneficial after resection surgery of high-risk GISTs [ 2 , 4 , 5 , 9 , 12 ]. In the case presented, the patient was submitted to radical surgical resection and then started Imatinib therapy, with a result of a follow-up period of 3 years without evidence of disease recurrence.…”